Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions

NCT ID: NCT01326195

Last Updated: 2011-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project is designed to develop and test a group-based preventive intervention to reduce dating violence and sexual risk behavior among adolescent females with prior dating violence exposure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A growing body of research reveals that dating violence (DV) plays a significant role in adolescent girls' HIV risk. Dating violence has been associated with less condom use, younger age at first intercourse, having multiple sex partners and alcohol use prior to sexual encounters. Thus, prevention strategies that address dating violence and HIV risk may hold promise for reducing sexual risk behavior among a particularly at-risk population. In this study, a cognitive-behaviorally based intervention named "Skills to Manage Aggression in Relationships for Teens" (Date S.M.A.R.T.) is being developed and compared to a psychoeducational program for dating violence and HIV prevention. The program is being implemented with a sample of underserved youth, as economic disadvantage and minority status have been found to be related to increased rates of adolescent dating violence. A primary focus of the intervention is to address mental health problems (i.e. psychological distress and behavioral dysregulation) that underlie the development and maintenance of both dating violence and sexual risk behavior among adolescent girls.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dating Violence HIV Infections

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

HIV Prevention Dating Violence Females Romantic relationships Adolescents Sexuality Underserved youth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Skills

Cognitive-Behavioral Dating Violence and HIV Prevention Group

Group Type EXPERIMENTAL

Cognitive-Behavioral Dating Violence and HIV Prevention Group

Intervention Type BEHAVIORAL

Six, two-hour weekly sessions and one 2-hour booster session 6 weeks later with adolescent females

Health Promotion

Psycho-educational Dating Violence and HIV Prevention group

Group Type ACTIVE_COMPARATOR

Psycho-educational Dating Violence and HIV prevention group

Intervention Type BEHAVIORAL

Knowledge based intervention matched for time and attention to skills arm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive-Behavioral Dating Violence and HIV Prevention Group

Six, two-hour weekly sessions and one 2-hour booster session 6 weeks later with adolescent females

Intervention Type BEHAVIORAL

Psycho-educational Dating Violence and HIV prevention group

Knowledge based intervention matched for time and attention to skills arm

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Date SMART

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescent must be English-speaking
* Adolescent must have a lifetime history of physical dating violence perpetration or victimization

Exclusion Criteria

* Current enrollment in an intervention for dating violence or HIV prevention
Minimum Eligible Age

15 Years

Maximum Eligible Age

17 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rhode Island Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rhode Island Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christie J. Rizzo, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Rhode Island Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rhode Island Hospital

Providence, Rhode Island, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christie J. Rizzo, Ph.D.

Role: CONTACT

Phone: 401-793-8064

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christie Rizzo, PhD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Rizzo CJ, Joppa M, Barker D, Collibee C, Zlotnick C, Brown LK. Project Date SMART: a Dating Violence (DV) and Sexual Risk Prevention Program for Adolescent Girls with Prior DV Exposure. Prev Sci. 2018 May;19(4):416-426. doi: 10.1007/s11121-018-0871-z.

Reference Type DERIVED
PMID: 29352400 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K23MH086328

Identifier Type: NIH

Identifier Source: org_study_id

View Link